Jonathan Lanfear is the Vice President and Head of R&D Business Development at Takeda Pharmaceuticals. Prior to joining Takeda in 2011, Mr. Lanfear spent approximately 8 years at Pfizer Inc. as a Senior Director and Transactions Lead in the Worldwide Business Development, Strategy, & Innovation group. Before joining Pfizer, Mr. Lanfear spent time as a Biotechnology Equity Analyst while employed at AG Edwards/Wachovia and in Business Development at Searle/Pharmacia, where he worked on several significant licensing transactions prior to the company’s acquisition. Mr. Lanfear holds a B.S. in Chemical Engineering and a Master’s degree in Bioengineering, both from the University of Michigan (Ann Arbor), and an MBA from Washington University (St. Louis). Mr. Lanfear currently serves on the board of directors of privately held Aquinnah Pharmaceuticals and ARTham Therapeutics, as well as publicly traded Molecular Templates, Inc.